Basaglar represents the first copycat version of Lantus. These insulin products mimic each other’s actions almost exactly; effectively they function identically within the body. Marketing prowess, insurance coverage and discounting to pharmacy benefit managers more than medical requirements dictate which product a person is likely to receive.